Male Breast Cancer Completed Phase 2 Trials for Aldesleukin (DB00041)

DBCOND0028546 (Male Breast Cancer)Completed2 IdentifierTitlePurposeDrugs
NCT00003199Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast CancerTreatment
NCT00006228Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast CancerTreatment